Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenwu Liu

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Alimentary Pharmacology & Therapeutics|August 1, 2018
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysisWenwu Liu, Yun Zheng, Wei He, et al.
American Journal of Cancer Research|November 12, 2021
A novel prognostic nomogram for hepatocellular carcinoma after thermal ablationQiang Tao, Qingjing Zeng, Wenwu Liu, et al.
European Journal of Medicinal Chemistry|January 7, 2022
Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's diseaseWenwu Liu, Xin Liu, Wenjie Liu, et al.
Bioorganic Chemistry|October 3, 2022
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatmentWenjie Liu, Liting Tian, Limeng Wu, et al.
European Journal of Medicinal Chemistry|August 25, 2022
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's diseaseWenjie Liu, Limeng Wu, Wenwu Liu, et al.
Bioorganic Chemistry|May 31, 2022
Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitorsYaoguang Huang, Wenwu Liu, Shuoqi Huang, et al.
Journal of Medicinal Chemistry|July 23, 2024
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's DiseaseHuanhua Chen, Xudong Gao, Xinzhu Li, et al.
Surgical Case Reports|March 18, 2024
Extended radical resection and chest wall reconstruction for a pulmonary sarcomatoid carcinoma: a case reportYingzhi Zhao, Shaohua Xie, Haoqian Zheng, et al.
Archiv Der Pharmazie|November 27, 2023
Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatmentJingsong Qiu, Xiangling Feng, Huanhua Chen, et al.
ACS Omega|January 16, 2023
Correction to Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer's DiseaseNan Wang, Wenjie Liu, Lijun Zhou, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Alimentary Pharmacology & Therapeutics|August 1, 2018
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysisWenwu Liu, Yun Zheng, Wei He, et al.
American Journal of Cancer Research|November 12, 2021
A novel prognostic nomogram for hepatocellular carcinoma after thermal ablationQiang Tao, Qingjing Zeng, Wenwu Liu, et al.
European Journal of Medicinal Chemistry|January 7, 2022
Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's diseaseWenwu Liu, Xin Liu, Wenjie Liu, et al.
Bioorganic Chemistry|October 3, 2022
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatmentWenjie Liu, Liting Tian, Limeng Wu, et al.
European Journal of Medicinal Chemistry|August 25, 2022
Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's diseaseWenjie Liu, Limeng Wu, Wenwu Liu, et al.
Bioorganic Chemistry|May 31, 2022
Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitorsYaoguang Huang, Wenwu Liu, Shuoqi Huang, et al.
Journal of Medicinal Chemistry|July 23, 2024
Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer's DiseaseHuanhua Chen, Xudong Gao, Xinzhu Li, et al.
Surgical Case Reports|March 18, 2024
Extended radical resection and chest wall reconstruction for a pulmonary sarcomatoid carcinoma: a case reportYingzhi Zhao, Shaohua Xie, Haoqian Zheng, et al.
Archiv Der Pharmazie|November 27, 2023
Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatmentJingsong Qiu, Xiangling Feng, Huanhua Chen, et al.
ACS Omega|January 16, 2023
Correction to Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer's DiseaseNan Wang, Wenjie Liu, Lijun Zhou, et al.
Pageof 15